RecruitingNCT05906147

Health ImprOvement Program of Bone in China


Sponsor

Second Xiangya Hospital of Central South University

Enrollment

5,000 participants

Start Date

Feb 27, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Fracture risk factors have long been identified as key factors in osteoporosis and fragility fractures. The WHO recommended Fracture risk assessmenttool (FRAX) applies clinical risk factors to assess the absolute risk of osteoporotic fractures in each individual. Our preliminary study suggests that FRAX estimates may underestimate the risk of fractures in the Chinese population. In order to optimize the risk prediction model of osteoporotic fractures, a treatment threshold and its optimal cutting point were initially established based on the data of the health management Center of the Second Xiangya Hospital of Central South University.


Eligibility

Min Age: 40 YearsMax Age: 100 Years

Inclusion Criteria1

  • Dual-energy X-ray bone mineral density measurement was performed in the health management center of our hospital in the physical examination subjects over 40 years old. Have independent civil capacity and agree to participate, and sign informed consent

Exclusion Criteria1

  • Under 40 years of age, Patients who had undergone hip replacement or lumbar surgery and could not perform dual-energy X-ray BMD testing; Patients who have been treated with effective anti-osteoporosis drugs or have a history of malignant tumors.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRegular follow-up

Follow-up of the population was conducted to track the incidence of fractures


Locations(1)

Health Management Center, The Second Xiangya Hospital of Central South University

Changsha, Hunan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05906147


Related Trials